TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 79 of 162 • 4,027 articles
TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

11/09/2025 09:18 AM • Tvardi Therapeutics experienced an 80% stock drop after disappointing Phase 2 clinical trial results for TTI-101 in idiopathic pulmonary fibrosis, with preliminary data showing the study did not meet its goals.

GOOG - Mentioned as providing warrant pledges, with no direct negative or positive implications
TVRD - Stock plummeted over 80% due to unsuccessful clinical trial results, indicating poor performance and potential investor losses
#clinical trial #pharmaceutical #stock drop #investor investigation
Read More
Could This Be the Most Overlooked Way to Profit From the Artificial Intelligence Software Boom?
The Motley Fool • Harsh Chauhan
Could This Be the Most Overlooked Way to Profit From the Artificial Intelligence Software Boom?

11/09/2025 09:12 AM • Confluent, a data streaming platform, offers a potentially undervalued opportunity in the AI software market, providing real-time data processing solutions that help companies deploy AI applications more effectively.

CFLT - The article highlights Confluent's strong potential in the AI market, with growing AI-native customer base, increasing revenue backlog, and an attractive PEG ratio of 0.34, suggesting the stock is undervalued
#AI software #data streaming #real-time processing #generative AI
Read More
SNPS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
SNPS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 09:12 AM • Faruqi & Faruqi is investigating potential claims against Synopsys for alleged securities law violations related to misleading statements about its Design IP business performance and AI customer focus.

GOOGL - Mentioned as providing warrant pledges, with no direct negative or positive implications
SNPS - Stock price dropped 35.8% after reporting underperforming IP business, 43% year-over-year decline in net income, and projected revenue decline, suggesting significant financial challenges
#securities lawsuit #class action #financial disclosure #artificial intelligence
Read More
AVTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
AVTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 09:10 AM • Faruqi & Faruqi is investigating potential securities claims against Avantor, alleging the company misled investors about its competitive positioning and market performance between March 2024 and October 2025.

TGT - Mentioned as one of the major employers conducting job cuts in 2025
AVTR - The company experienced significant stock price declines, reduced financial guidance, leadership changes, reported losses, and admitted to competitive pressures negatively impacting business performance
#securities litigation #class action #investor losses #competitive positioning
Read More
Better U.S. Treasury ETF: Schwab Long-Term U.S. Treasury vs. Vanguard Long-Term Treasury
The Motley Fool • Robert Izquierdo
Better U.S. Treasury ETF: Schwab Long-Term U.S. Treasury vs. Vanguard Long-Term Treasury

11/09/2025 09:05 AM • The article compares two long-term U.S. Treasury ETFs from Schwab and Vanguard, analyzing their expense ratios, performance, dividend yields, and overall investment potential for government bond investors.

META - Mentioned as one of the major employers conducting job cuts in 2025
SCHQ - Offers competitive expense ratio, comparable returns, strong performance, and cost-effectiveness with 95 holdings focused on long-term U.S. Treasury bonds
#ETF #Treasury bonds #long-term investment #government securities #dividend yield
Read More
NJDCY SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec
GlobeNewswire Inc. • James (Josh) Wilson
NJDCY SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

11/09/2025 09:04 AM • Nidec Corporation is under investigation for suspected improper accounting practices, leading to significant stock price declines and a Tokyo Stock Exchange special security alert.

SBUX - Mentioned as one of the major employers conducting job cuts in 2025
NJDCY - Multiple investigations revealed potential accounting misconduct, stock price dropped substantially (over 68% across several disclosures), and Tokyo Stock Exchange issued a special security alert due to identified internal control deficiencies
#accounting irregularities #stock investigation #internal controls
Read More
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
GlobeNewswire Inc. • Marat Fudim, Md, Mhs
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

11/09/2025 09:00 AM • Medera Inc. announced positive interim data from its MUSIC-HFpEF Phase 1/2a clinical trial for a gene therapy treatment targeting heart failure with preserved ejection fraction (HFpEF), demonstrating a favorable safety profile and early clinical benefits in treated patients.

JPMpC - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
AZN - Mentioned as a collaborator in developing HFpEF disease model, with no specific performance details provided
#gene therapy #heart failure #clinical trial #SERCA2a #cardiovascular disease
Read More
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
GlobeNewswire Inc. • Monopar Therapeutics Inc.
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

11/09/2025 09:00 AM • Monopar Therapeutics presented new data at AASLD showing that ALXN1840 (tiomolybdate choline) rapidly improved copper balance in Wilson disease patients through increased fecal copper excretion.

JPM - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
MNPR - Presented promising clinical study results demonstrating potential effectiveness of their drug ALXN1840 in treating Wilson disease, indicating positive research progress
#Wilson disease #copper balance #tiomolybdate choline #clinical study #liver disease
Read More
WPP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that WPP Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
WPP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that WPP Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:57 AM • Faruqi & Faruqi is investigating potential securities law violations by WPP, alleging false statements about revenue expectations and market performance during the first half of 2025, which led to a significant stock price decline.

JPMpD - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
WPP - The company experienced an 18.1% stock price drop after revealing performance deterioration, alleged misleading statements about market performance, and challenges in its media division amid macroeconomic uncertainties
#securities litigation #class action #stock decline #revenue expectations #investor losses
Read More
NX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Quanex Building Products Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
NX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Quanex Building Products Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:56 AM • Quanex Building Products faces potential securities lawsuit over alleged misleading statements regarding operational issues in its Mexico facility, with stock price declining after disclosing significant financial and operational challenges.

JPMpJ - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
NX - Company disclosed significant operational challenges in Mexico facility, reported substantial financial losses (EPS of -$6.04), acknowledged underinvestment in equipment maintenance, and experienced stock price decline of over 23% in two trading days
#securities lawsuit #class action #financial disclosure #operational issues #Tyman integration
Read More
MOH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Molina Healthcare Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
MOH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Molina Healthcare Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:52 AM • Molina Healthcare faces potential securities class action lawsuit after reducing financial guidance twice in July 2025, citing medical cost pressures and challenging market conditions.

JPMpK - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
MOH - Company significantly reduced full-year earnings guidance twice within two weeks, from $24.50 to $19.00 per share, attributed to medical cost pressures and decreased performance across business lines
#securities litigation #medical cost trend #earnings guidance #class action
Read More
LNTH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
LNTH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:50 AM • Faruqi & Faruqi is investigating potential claims against Lantheus Holdings regarding misleading statements about Pylarify's competitive position, with stock price dropping 28.8% after disappointing Q1 and fiscal year results.

JPMpL - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
LNTH - Stock price declined 28.8% after reporting below-market Q1 results, reduced growth expectations for Pylarify, and acknowledging competitive challenges impacting pricing dynamics
#securities litigation #class action #shareholder lawsuit #stock decline
Read More
LRN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride
GlobeNewswire Inc. • James (Josh) Wilson
LRN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride

11/09/2025 08:47 AM • Faruqi & Faruqi is investigating potential claims against Stride Inc. after the company experienced significant stock price drops following allegations of fraud and enrollment challenges.

JPMpM - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
LRN - Stock price dropped 11.7% after fraud allegations and another 51% after revealing enrollment and system implementation issues, indicating significant investor concerns about company performance and potential legal challenges
#securities litigation #enrollment fraud #stock price decline
Read More
Meet the Newest Addition to the S&P 500. The Stock Has Soared 200% Since Early Last Year, and Is Still a Buy Right Now, According to 1 Wall Street Analyst.
The Motley Fool • Neha Chamaria
Meet the Newest Addition to the S&P 500. The Stock Has Soared 200% Since Early Last Year, and Is Still a Buy Right Now, According to 1 Wall Street Analyst.

11/09/2025 08:20 AM • Emcor Group, a specialty infrastructure services contractor, recently joined the S&P 500 index and has seen remarkable stock growth of 200% since early 2024, driven by strong demand in AI data centers and infrastructure projects.

PLTR - Tumbled 7.51% despite strong earnings, with Michael Burry's fund purchasing significant put options
EME - Stock has soared 200% since early 2024, has record revenue and RPOs, strong growth in AI and data center markets, projected 15% revenue growth in 2025, and received a buy rating from Wall Street analyst with a potential 23% upside
#S&P 500 #AI #data centers #infrastructure #specialty contractor
Read More
As Warren Buffett Prepares to Step Down, His Warning to Wall Street Is Now at Ear-Shattering Levels
The Motley Fool • Bram Berkowitz
As Warren Buffett Prepares to Step Down, His Warning to Wall Street Is Now at Ear-Shattering Levels

11/09/2025 08:20 AM • Warren Buffett is stepping down as CEO of Berkshire Hathaway at year-end, with the company showing cautious market sentiment by accumulating cash and selling stocks, indicating potential market overvaluation.

DENN - Surged 49.15% after announcing definitive agreement to be acquired for approximately $620 million
BRK.A - Maintaining large cash reserves, being selective about investments, and showing caution about current market valuations
#Warren Buffett #market valuation #cash reserves #stock market #investment strategy
Read More
Bitcoin's
The Motley Fool • Leo Sun
Bitcoin's "Uptober" Was a Bust for 2025. Here's What That Means for the Leading Crytocurrency.

11/09/2025 08:15 AM • Bitcoin experienced its first negative October since 2018, dropping 5% despite previous strong performance. The decline was attributed to elevated Treasury yields, profit-taking, and reduced investor support, though long-term prospects remain promising.

TCPC - Mentioned as one of the institutional investors supporting Bitcoin's broader adoption
#Bitcoin #cryptocurrency #halving #ETF #Federal Reserve #interest rates
Read More
Got About $45? This Is a Great Dividend Stock to Buy Right Now.
The Motley Fool • Matt Dilallo
Got About $45? This Is a Great Dividend Stock to Buy Right Now.

11/09/2025 08:09 AM • Brookfield Renewable offers a high-yielding dividend stock with potential for significant growth, driven by renewable energy investments, long-term contracts, and expansion in sustainable energy solutions.

BEPC - High dividend yield of 3.4%, stable cash flow, projected 5-9% annual dividend growth, and strong growth potential through long-term contracts, margin enhancements, and renewable energy development
#dividend #renewable energy #investment #sustainable solutions #energy infrastructure
Read More
Prediction: XRP (Ripple) Will Surge Past This Price by 2029
The Motley Fool • Adam Levy
Prediction: XRP (Ripple) Will Surge Past This Price by 2029

11/09/2025 08:05 AM • The article predicts XRP could reach over $10 by 2029, driven by positive regulatory developments, resolution of SEC lawsuit, and growing institutional interest in blockchain technology for cross-border transactions.

SAN - Mentioned as testing RippleNet, indicating potential interest in blockchain technology
#XRP #Ripple #cryptocurrency #blockchain #SEC #ETF #cross-border transactions
Read More
What Roblox Could Look Like in 5 Years
The Motley Fool • Lawrence Nga
What Roblox Could Look Like in 5 Years

11/09/2025 07:27 AM • Roblox is poised for potential transformation by 2030, with three key trends: immersive advertising, an aging user base, and international expansion potentially reshaping its business model from a gaming platform to a diverse digital economy.

ARKQ - Actively managed by Cathie Wood, focuses on innovative robotics and automation technologies with unique stock selections
RBLX - The article suggests multiple growth opportunities including ad revenue potential, expanding user demographics, and international market expansion, which could lead to higher margins and more sustainable revenue
#Roblox #metaverse #digital platform #advertising #user demographics #international growth
Read More
1 Reason Nvidia Is the Smartest AI Stock to Buy With $100 Right Now
The Motley Fool • Ryan Vanzo
1 Reason Nvidia Is the Smartest AI Stock to Buy With $100 Right Now

11/09/2025 07:15 AM • Nvidia is recommended as a core AI investment, offering investors insight into the AI landscape by providing exposure to the largest GPU supplier for artificial intelligence applications.

NVDA - Top holding in Global X ETF, provides critical AI chips for robotics applications
NVDA - The article portrays Nvidia as a critical player in AI technology, highlighting its market leadership, GPU dominance, and potential for investor education about the AI industry
#AI #GPU #technology investment #data centers #chip manufacturing
Read More
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio?
Benzinga • Nabaparna Bhattacharya
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio?

11/09/2025 07:08 AM • Multiple large-cap companies reported strong Q3 earnings and raised fiscal year guidance, leading to significant stock price gains across various sectors including technology, travel, and healthcare.

TSLA - Top holding in Ark ETF, has significant robotics ambitions
GMED - Gained 39.79% after better-than-expected Q3 results and raised fiscal year 2025 guidance
#earnings #stock performance #Q3 results #guidance #large-cap stocks
Read More
KMX CLASS REMINDER: CarMax, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by January 2 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
KMX CLASS REMINDER: CarMax, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by January 2 Legal Deadline

11/09/2025 07:07 AM • CarMax faces a securities fraud class action lawsuit after reporting disappointing financial results, including sales declines and an unexpected CEO departure, which triggered a significant stock price drop.

KMX - Stock price dropped 20% after Q2 financial results, experienced sales declines across retail and wholesale units, and faced unexpected CEO departure, indicating significant business challenges
#securities fraud #stock drop #financial performance #class action lawsuit
Read More
JAMF INVESTIGATION REMINDER: The Jamf Holding Corp. Board May have Breached its Fiduciary Duties – Shareholders Urged to Contact BFA Law
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
JAMF INVESTIGATION REMINDER: The Jamf Holding Corp. Board May have Breached its Fiduciary Duties – Shareholders Urged to Contact BFA Law

11/09/2025 07:07 AM • Law firm investigating potential breach of fiduciary duties by Jamf Holding Corp.'s board regarding a take-private sale by Francisco Partners Management at $13.05 per share, with concerns about Vista Equity Partners' significant influence.

JAMF - Potential board misconduct, potential undervaluation of stock, conflict of interest concerns with Vista Equity Partners' significant ownership and board representation
#securities investigation #take-private sale #fiduciary duties #shareholder rights
Read More
JHX CLASS REMINDER: James Hardie Industries plc Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 23 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
JHX CLASS REMINDER: James Hardie Industries plc Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 23 Legal Deadline

11/09/2025 07:07 AM • A class action lawsuit alleges James Hardie Industries misrepresented its North American fiber cement sales performance, with stock dropping 34% after revealing significant inventory destocking and declining sales.

JHX - Company accused of fraudulent channel stuffing, misrepresenting sales performance, and experiencing significant stock price decline after revealing true sales conditions
#securities fraud #class action #stock decline #inventory manipulation
Read More
SNPS CLASS REMINDER: Synopsys, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 30 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
SNPS CLASS REMINDER: Synopsys, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 30 Legal Deadline

11/09/2025 07:07 AM • A class action lawsuit alleges Synopsys misled investors about its Design IP business performance, resulting in a significant stock price drop after revealing challenges with customer customization and business model issues.

SNPS - Stock dropped 36% after revealing underperformance in Design IP segment, declining revenue, increased customer customization challenges, and potential business model disruption
#securities fraud #class action #stock decline #design automation #IP components
Read More